Technical Analysis for COLL - Collegium Pharmaceutical, Inc.

Grade Last Price % Change Price Change
grade C 24.95 -0.28% -0.07
COLL closed down 0.28 percent on Thursday, May 24, 2018, on 43 percent of normal volume. It was able to find support at its 50 day moving average.

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Down
See historical COLL trend table...

Date Alert Name Type % Chg
May 24 50 DMA Support Bullish 0.00%
May 24 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
May 24 Doji - Bullish? Reversal 0.00%
May 24 Down 3 Days in a Row Weakness 0.00%
May 24 Down 4 Days in a Row Weakness 0.00%
May 23 Outside Day Range Expansion -0.28%
May 23 Down 3 Days in a Row Weakness -0.28%
May 22 Narrow Range Bar Range Contraction -0.91%
May 22 NR7 Range Contraction -0.91%
May 22 NR7-2 Range Contraction -0.91%

Older signals for COLL ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, focuses on developing and commercializing abuse-deterrent products that incorporate its DETERx platform technology for the treatment of chronic pain and other diseases. Its lead product candidate is Xtampza, an abuse-deterrent, extended-release, oral formulation of oxycodone, a prescribed opioid medication. The company is also developing COL-172, an abuse-deterrent, extended-release oxymorphone for the treatment of chronic pain; COL-195, an abuse-deterrent, extended-release hydrocodone for the treatment of chronic pain; COL-196, a morphine formulation for the treatment of pain; and COL-171, a proprietary preclinical DETERx extended-release, abuse-deterrent methylphenidate formulation for the treatment of attention deficit hyperactivity disorder. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Canton, Massachusetts.
Is COLL a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 29.9
52 Week Low 8.01
Average Volume 423,325
200-Day Moving Average 18.3421
50-Day Moving Average 24.6358
20-Day Moving Average 24.462
10-Day Moving Average 25.207
Average True Range 1.3935
ADX 17.04
+DI 20.94
-DI 17.97
Chandelier Exit (Long, 3 ATRs ) 22.8195
Chandelier Exit (Short, 3 ATRs ) 25.8205
Upper Bollinger Band 26.5267
Lower Bollinger Band 22.3973
Percent B (%b) 0.62
BandWidth 16.880876
MACD Line 0.2981
MACD Signal Line 0.2154
MACD Histogram 0.0827
Fundamentals Value
Market Cap 737.68 Million
Num Shares 29.6 Million
EPS -3.59
Price-to-Earnings (P/E) Ratio -6.95
Price-to-Sales 40.60
Price-to-Book 3.16
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 26.06
Resistance 3 (R3) 26.00 25.57 25.88
Resistance 2 (R2) 25.57 25.29 25.60 25.81
Resistance 1 (R1) 25.26 25.11 25.05 25.32 25.75
Pivot Point 24.83 24.83 24.72 24.86 24.83
Support 1 (S1) 24.52 24.55 24.31 24.58 24.15
Support 2 (S2) 24.09 24.37 24.12 24.09
Support 3 (S3) 23.78 24.09 24.03
Support 4 (S4) 23.84